Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Mr. Pohl / ptscman, the Q reports warrant conversion

Apr 19, 2007 10:03AM

Apr 19, 2007 10:59AM

Apr 19, 2007 11:10AM

Apr 19, 2007 11:15AM

Apr 19, 2007 11:19AM

Apr 19, 2007 11:27AM

Apr 19, 2007 11:33AM

Apr 19, 2007 11:35AM

Apr 19, 2007 11:54AM

Apr 19, 2007 11:55AM

Apr 19, 2007 11:56AM

Apr 19, 2007 11:59AM

Apr 19, 2007 12:06PM

Apr 19, 2007 01:22PM

Re: Mr. Pohl / ptscman, the Q reports warrant conversion

in response to by
posted on Apr 19, 2007 01:28PM

and, while late, the Q reports are published.  Were / Are you looking for a more formal discussion of the S & L deal?

If so, then I'm not sure what management could have done or do.  As many have complained, they have choosen to let S & L play out their warrants.  One of the mysteries mentioned by several here is WHY S&L converts and sells now, at this price.  My guess (WAG) would be to diversify their total holdings.  S&L has zero responsibility to PTSC's sharholders and they may want to convert all of the warrants prior to the Markman results being known. 

Again, just my guess, but I would like to see another reduction in the warrants held on the coming Q report next week (in theory).

John

Share
New Message
Please login to post a reply